MannKind Corp. (MNKD)

[Phaeton]

Why is big Pharma afraid of MannKind. Perhaps we have found the answer with this user on Proboard and his comment. Maybe even Sanofi might be bagging on Afrezza as its usage might mean using less insulin and that is not good if your a big seller of Lantus or Tuojeo. I can see why big Pharma is working hard to kill ManKind and Afrezza.

You can't make this up!

--------------------------------------------------
pmikeks
Researcher
***
2 hours ago
liane, spiro and 2 more like this. Quote
"
I have been on Affrezza three months. When I started my A1c was 9.2 and I fully expect it to be under 6.0 when I have my follow up this week. I was taking 30 units of Lantus nightly when I started and granted I wasn't behaving as I should. But now when I do splurge (example; pizza and homemade ice cream) my peak isn't as high and doesn't last as long.
Many days at bedtime my blood sugar is under 100 so I don't take Lantus and my fasting blood sugar is still under 100 come morning. Other days because my count is under 130 I take a lesser amount of Lantus (15-25 units). Sooo.as a result I'm using less then a third of the Lantus I was taking to start with. It's like my pancreas has decided to jump in and help. It didn't happen immediately or even with consistent improvement
Are my results after three months typical? I don't have the answer to that. If they are typical it may be part of why SNY isn't as enthusiastic as we would like them to be in promoting Affrezza."